Interestingly, inhibition of PP1/PP2A by using okadaic acid or calyculin A has been reported to reduce tumor resistance to radiation or chemotherapy [155], confirming the veracity of these phosphatase inhibitors at the therapeutic level. The gene discussed is PTPA; the disease is neoplasm.